Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Beta Bionics (BBNX) stock in plain English

Free brief · no signupStart here
BBNXPublished Nov 19, 2026
Beta Bionics Inc
Healthcare · Medical Devices
Manufactures and sells an automated bionic pancreas system for managing type 1 diabetes.
Assets:
iLet Bionic PancreasFDA-cleared pocket-sized automated insulin delivery system
Massachusetts and CaliforniaDual operating facilities in Concord and Irvine
Specialized workforceEmploys biomedical engineers, clinical staff, and certified diabetes specialists
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

69
OPS ScoreOperating finances
Latest quote
-7.05%$13.32
$724.17M
n/a (loss)
$127.27M

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was BBNX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Beta Bionics (BBNX) do?

Beta Bionics Inc (BBNX) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures and sells an automated bionic pancreas system for managing type 1 diabetes. Builds autonomous insulin delivery systems requiring only body weight input rather than precise carbohydrate counting. It is worth $724.17M on the market and sold $127.27M over the last year.

Market cap
$724.17M
P/E ratio
None (reported a loss)
Annual sales
$127.27M
Sector
Healthcare
Industry
Medical Devices
Brief updated
Nov 19, 2026

Brands and businesses behind BBNX

  • iLet: Automated insulin delivery system that eliminates carb counting, earning revenue through hardware sales and recurring disposable supplies.

BBNX’s flags, in plain English

Each flag is a number from Beta Bionics’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Stupid Cash

Can pay this year's bills 8.9 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Low debt

Low debt, only 2% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Wide Gross Margin

Gross margin of 58.6% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Burning Cash

Losing money, profit margin of -65.3%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.

1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.

Questions about BBNX

How big is Beta Bionics?

Beta Bionics’ market cap is $724.17M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $127.27M: what customers paid the company over the last year, before any costs.

What is BBNX’s P/E ratio?

BBNX has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with BBNX?

The business relies on a single commercial device, the iLet system, for virtually all of its revenue. That is one risk on Beta Bionics’ card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Beta Bionics’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BBNX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card